关于“有远见的”干预成瘾药物的数据不断积累。 - Suppr

Suppr

超能文献

Data accrue on "visionary" agent to interrupt addiction.

作者信息

Morris K

出版信息

Lancet. 1999 Nov 27;354(9193):1883. doi: 10.1016/S0140-6736(05)76849-5.

DOI:10.1016/S0140-6736(05)76849-5

PMID:10584734

Abstract

摘要

相似文献

Data accrue on "visionary" agent to interrupt addiction.

Lancet. 1999 Nov 27;354(9193):1883. doi: 10.1016/S0140-6736(05)76849-5.

100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

Pharmacol Rev. 1995 Jun;47(2):235-53.

[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].

Medicina (Kaunas). 2004;40(3):216-9.

The ibogaine medical subculture.

J Ethnopharmacol. 2008 Jan 4;115(1):9-24. doi: 10.1016/j.jep.2007.08.034. Epub 2007 Aug 25.

DARK Classics in Chemical Neuroscience: Ibogaine.

ACS Chem Neurosci. 2018 Oct 17;9(10):2475-2483. doi: 10.1021/acschemneuro.8b00294. Epub 2018 Oct 9.

Treating drug dependence with the aid of ibogaine: a retrospective study.

J Psychopharmacol. 2014 Nov;28(11):993-1000. doi: 10.1177/0269881114552713. Epub 2014 Sep 29.

Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.

Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1019-1022. doi: 10.1080/17425255.2021.1944099. Epub 2021 Jun 24.

Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.

Science. 2005 Apr 15;308(5720):345-6. doi: 10.1126/science.308.5720.345.

Observations on treatment with ibogaine.

Am J Addict. 1998 Winter;7(1):89-90. doi: 10.1111/j.1521-0391.1998.tb00472.x.

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Prog Brain Res. 2018;242:217-257. doi: 10.1016/bs.pbr.2018.08.005. Epub 2018 Oct 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Data accrue on "visionary" agent to interrupt addiction.

Lancet. 1999 Nov 27;354(9193):1883. doi: 10.1016/S0140-6736(05)76849-5.

100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

Pharmacol Rev. 1995 Jun;47(2):235-53.

[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].

Medicina (Kaunas). 2004;40(3):216-9.

The ibogaine medical subculture.

J Ethnopharmacol. 2008 Jan 4;115(1):9-24. doi: 10.1016/j.jep.2007.08.034. Epub 2007 Aug 25.

DARK Classics in Chemical Neuroscience: Ibogaine.

ACS Chem Neurosci. 2018 Oct 17;9(10):2475-2483. doi: 10.1021/acschemneuro.8b00294. Epub 2018 Oct 9.

Treating drug dependence with the aid of ibogaine: a retrospective study.

J Psychopharmacol. 2014 Nov;28(11):993-1000. doi: 10.1177/0269881114552713. Epub 2014 Sep 29.

Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.

Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1019-1022. doi: 10.1080/17425255.2021.1944099. Epub 2021 Jun 24.

Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.

Science. 2005 Apr 15;308(5720):345-6. doi: 10.1126/science.308.5720.345.

Observations on treatment with ibogaine.

Am J Addict. 1998 Winter;7(1):89-90. doi: 10.1111/j.1521-0391.1998.tb00472.x.

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Prog Brain Res. 2018;242:217-257. doi: 10.1016/bs.pbr.2018.08.005. Epub 2018 Oct 12.